Dabigatran etexilate mesylate 872728-81-9 98%

Emnar was established in 2005, with a drive to become as the premier integrated pharmaceuticals company in India. Its business focuses on Contract Manufacturing, Custom Synthesis, FTE Research, and the manufacture and marketing of pharmaceuticals products and services to clients across the globe, and its product portfolio includes a range of Active Pharmaceutical Ingredients (APIs), Fine Intermediates.

Mission

To provide pharmaceutical and healthcare products in cost effective ways by setting the highest standards in quality, service, reliability and safety.

Vision

At Emnar we will focus on innovation and core values towards achieving excellence across all operations. We will endeavor to adopt environmentally friendly practices and manufacture products with highest quality and reliability to emerge as a leader in the integrated pharmaceuticals business.

Addressing Environmental Concerns

During the past 6 years, Emnar sales have more than doubled, but our emissions and use of natural resources have grown much more slowly.We aim to use natural resources efficiently and minimize the environmental impacts of our activities and products during their life cycles.

Emnar is committed to provide safe workplaces for all Group companies. Improvement in safety performance owes as much to management attention and well-trained associates as to elaborately engineered systems. We believe our safety culture and behavior-based safety programs are key to the continued improvement of occupational health and safety.We work to minimize emissions to air and water, carefully monitoring volatile organic compounds and greenhouse-gas emissions, as well as effluents, in accordance with international standards.